Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nanosilver Mitigates Biofilm Formation via FapC Amyloidosis Inhibition.
Huma ZE, Javed I, Zhang Z, Bilal H, Sun Y, Hussain SZ, Davis TP, Otzen DE, Landersdorfer CB, Ding F, Hussain I, Ke PC. Huma ZE, et al. Among authors: bilal h. Small. 2020 May;16(21):e1906674. doi: 10.1002/smll.201906674. Epub 2020 Jan 27. Small. 2020. PMID: 31984626 Free PMC article.
Synergistic Meropenem-Tobramycin Combination Dosage Regimens against Clinical Hypermutable Pseudomonas aeruginosa at Simulated Epithelial Lining Fluid Concentrations in a Dynamic Biofilm Model.
Bilal H, Bergen PJ, Kim TH, Chung SE, Peleg AY, Oliver A, Nation RL, Landersdorfer CB. Bilal H, et al. Antimicrob Agents Chemother. 2019 Oct 22;63(11):e01293-19. doi: 10.1128/AAC.01293-19. Print 2019 Nov. Antimicrob Agents Chemother. 2019. PMID: 31427301 Free PMC article.
Clinically Relevant Epithelial Lining Fluid Concentrations of Meropenem with Ciprofloxacin Provide Synergistic Killing and Resistance Suppression of Hypermutable Pseudomonas aeruginosa in a Dynamic Biofilm Model.
Bilal H, Bergen PJ, Tait JR, Wallis SC, Peleg AY, Roberts JA, Oliver A, Nation RL, Landersdorfer CB. Bilal H, et al. Antimicrob Agents Chemother. 2020 Jun 23;64(7):e00469-20. doi: 10.1128/AAC.00469-20. Print 2020 Jun 23. Antimicrob Agents Chemother. 2020. PMID: 32366710 Free PMC article.
Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling.
Bilal H, Tait JR, Lang Y, Zhou J, Bergen PJ, Peleg AY, Bulitta JB, Oliver A, Nation RL, Landersdorfer CB. Bilal H, et al. Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0220321. doi: 10.1128/aac.02203-21. Epub 2022 Jan 18. Antimicrob Agents Chemother. 2022. PMID: 35041509 Free PMC article.
Pharmacodynamics of ceftazidime plus tobramycin combination dosage regimens against hypermutable Pseudomonas aeruginosa isolates at simulated epithelial lining fluid concentrations in a dynamic in vitro infection model.
Tait JR, Bilal H, Kim TH, Oh A, Peleg AY, Boyce JD, Oliver A, Bergen PJ, Nation RL, Landersdorfer CB. Tait JR, et al. Among authors: bilal h. J Glob Antimicrob Resist. 2021 Sep;26:55-63. doi: 10.1016/j.jgar.2021.04.021. Epub 2021 May 21. J Glob Antimicrob Resist. 2021. PMID: 34023531 Free article.
Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model.
Tait JR, Bilal H, Rogers KE, Lang Y, Kim TH, Zhou J, Wallis SC, Bulitta JB, Kirkpatrick CMJ, Paterson DL, Lipman J, Bergen PJ, Roberts JA, Nation RL, Landersdorfer CB. Tait JR, et al. Among authors: bilal h. Antibiotics (Basel). 2022 Jan 13;11(1):101. doi: 10.3390/antibiotics11010101. Antibiotics (Basel). 2022. PMID: 35052977 Free PMC article.
Interleukin inhibitors and the associated risk of candidiasis.
Khan S, Bilal H, Khan MN, Fang W, Chang W, Yin B, Song NJ, Liu Z, Zhang D, Yao F, Wang X, Wang Q, Cai L, Hou B, Wang J, Mao C, Liu L, Zeng Y. Khan S, et al. Among authors: bilal h. Front Immunol. 2024 Mar 28;15:1372693. doi: 10.3389/fimmu.2024.1372693. eCollection 2024. Front Immunol. 2024. PMID: 38605952 Free PMC article. Review.
123 results